AbbVie 因第一季度业绩超出预期，上调2026年展望至14.28美元

AbbVie (NYSE:ABBV) is starting to regain its footing at a critical moment, with the company lifting its full-year outlook after delivering a first-quarter beat that came in ahead of expectations on both earnings and revenue. Adjusted earnings reached $2.65 a share, topping estimates of $2.60, while revenue rose to $15 billion, also exceeding forecasts. Management now expects 2026 adjusted earnings of as much as $14.

该内容为新闻快讯，正文已简化。请通过原文链接查看完整内容。